Skip to content

Study on the Safety of Painless Gastrointestinal Endoscopes After COVID-19 Infection by Preoxygenation

Study on the Safety of Painless Gastrointestinal Endoscopes After COVID-19 Infection by Preoxygenation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300069484
Enrollment
Unknown
Registered
2023-03-18
Start date
2023-03-10
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19 Infection

Interventions

Nasal catheter oxygen inhalation group:N/A
Nasal catheter+mask oxygen inhalation group:N/A

Sponsors

Shenzhen Second People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-70 years; People with ten major symptoms of COVID-19 infection after December 8, 2022; 2. Patients who plan to undergo painless Gastrointestinal Endoscopes; 3. American Association of Anesthesiologists (ASA) Grade I-II; 4. No communication barrier, able to cooperate with intervention; 5. All patients signed the informed consent for diagnosis and treatment of digestive endoscopy and the risk notification of COVID-19 infection.

Exclusion criteria

Exclusion criteria: 1. Pregnancy or lactation; 2. Patients with difficult airway and may need tracheal intubation for diagnosis and treatment; 3. People with a history of severe sleep apnea, snoring, lung diseases (such as pneumothorax, asthma, etc.); 4. Severe nasal congestion, recent nasal trauma, nasal surgery; Recent acute inflammation of mouth and throat; 5. Complicated with severe cardiopulmonary disease; 6. Patients who are judged by the researcher to be unsuitable for this study.

Design outcomes

Primary

MeasureTime frame
Change of SPO2;hypoxemia incidence;

Secondary

MeasureTime frame
Incidence of cough;Whether the inspection is completed;

Countries

China

Contacts

Public ContactLi Hualin

Shenzhen Second People's Hospital

1577958147@qq.com+86 13823562128

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026